Orthobiologics Market Share To 2026 Anticipeted By Global Key Players

Orthobiologics
are substances used to heal injuries such as fractures and injured
muscles, ligaments, and tendons within a short period of time.
Orthobiologics are made from substances that naturally occur in the
body. Some examples of orthobiologics are bone grafts, autologous
blood, autologous conditioned serum, platelet rich plasma, growth
factors, and stem cells.
Increasing
prevalence of injury and facture due to falls and road accidents are
expected to augment growth of the orthobiologics market
According to World
Health Organization (WHO), 2017, fatal falls are the second-leading
cause of accidental injury and factures worldwide. Every year around
646000 individuals die from falls, globally. Increasing incidence of
fall is expected to increase the chances of fractures, which in turn,
is expected to create a highly conductive environment for growth of
the orthobiologics market over the forecast period.
According to World
Health Organization (WHO), in 2017, around 1.25 million deaths were
recorded and 20 to 50 million people suffered from severe injuries
and fractures. Increasing prevalence of factures due to road
accidents is expected to boost growth of the orthobiologics market in
the near future. According to National Institute of Health (NIH), in
2016, around 8.5%, accounting for around 617 million of the world
population was aged 65 years and above. Growing geriatric population,
which is highly susceptible to injuries and fractures due to fragile
skeletal framework, is increasing the prevalence of orthopedic
disorders, in turn, driving growth of the orthobiologics market. The
major factor restraining market growth is the high cost associated
with orthobiologics-based treatments.
Global
Orthobiologics Market Taxonomy
The global
orthobiologics market is segmented on the basis of product type,
application, and end user.
By Product Type
Demineralized
Bone Matrix (DBM)
Allograft
Bone
Morphogenetic Protein (BMP)
Viscosupplementation Products
Synthetic Bone
Substitutes
Stem Cell
Therapy
By Application
Osteoarthritis
and Degenerative Arthritis
Spinal Fusion
Fracture
Recovery
Soft Tissue
Injuries
Maxillofacial
and Dental Applications
By End User
Hospitals
Ambulatory Care
Centers
Dental Clinics
Ask For Discount
Before Purchasing This Business Report @
https://www.coherentmarketinsights.com/insight/request-discount/1306
North America is
expected to hold a dominant position due to rapid development of new
innovative products by key players present in region
North America is
expected to hold a dominant position in the orthobiologics market due
to rampant research activities and rapid development of innovative
products by key players present in the region. For instance, in 2015,
NuVasive Inc.—U.S.-based company—launched its new innovative
biologics technology, AttraX Putty, which is a synthetic bone graft,
indicated in posterolateral spinal surgery as an autograft extender.
Asia Pacific is expected to witness rapid growth, owing to growing
geriatric population in the region. According to The United Nations
Economic and Social Commission for Asia and the Pacific (ESCAP),
2016, the Asia Pacific region recorded around 60 percent of the
geriatric population across the globe. The region recorded around 547
million people aged 65 years and above, which is projected to reach
up to 1.3 billion by 2050.
Major players in the
market are focusing on inorganic growth strategies such as mergers
and acquisitions, to enhance their foothold in the global
orthobiologics market. For instance, in May 2015, Bone Biologics
Corp. collaborated with the University of California for the
development of Nell-1, a bone growth stimulator orthobiological
product.
Key players
operating in the orthobiologics market include Medtronic Plc, DePuy
Synthes, Inc., Zimmer Biomet Holdings, Inc., Bone Biologics Corp,
Harvest Technologies Corporation, Globus Medical, Inc., Smith &
Nephew plc. NuVasive Inc., Stryker Corporation, and Genzyme.
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment